Table 4.
RESLES type 1 | RESLES type 2 | ||||
---|---|---|---|---|---|
MERS type 1 | MERS type 2 | ||||
Infection | Infuenza B (24), rotavirus, herpes virus-6 (24), Epstein-Barr virus (24), puumala hantavirus (50), mumps virus (26) | Infuenza A (9, 59), VZV (25), adenovirus (63), nonfulminant hepatitis A (62), klebsiella pneumoniae (46), meningococcal meningitis (12), Mycoplasma pneumoniae (26, 27, 41, 46, 56), legionella pneumophila (37), tick-bites (38) | Epstein-Barr virus (64, 67) | ||
Seizures | Seizure (71) | ||||
Drug | Ipilimumba (57), sympathomimetic (55), minocycline (51) | ||||
Use of AEDs | Phenytoin (1, 52), carbamazepine (3), vigabatrin (52) | Olanzapine (7) | |||
withdrawal of AEDs | Valproate (26), oxcarbazepine (5, 33), topiramate (30), levetiracetam (34), phenytoin (3, 42), carbamazepine (72) | Oxcarbazepine (33) | |||
Autoimmune disease | Anti-Yo rhombencehhalitis (39) | ||||
Metabolic disturbances | Hypoglycemia (40, 48), methyl bromide poisoning (43), glufosinate ammonium poisoning (15), anorexia nervosa (73) | Amanita phalloides intoxication (61), hemolytic uremic syndrome (44) | Carbon monoxide poisoning (26), hypoglycemia (26, 70), MBD (26), osmotic myelinolysis (13) | ||
Miscellaneous conditions | cerebral venous thrombus (22), Anti-VGKC autoantibody syndrome (21), Charcot-Marie-Tooth disease (74), blood transfusion (49), migraine with aura (75) |
Notes: All etiologies in MERS column also be etiologies of RESLES but are not listed in RESLES column now. MERS: mild encephalitis with a reversible splenial lesion syndrome, AEDs: antiepileptic drugs, VZV: varicella zoster virus, VGKC: voltage-gated potassium channel, MBD: Marchiafava-Bignami disease